Featured Content

Vaginal Ring Linked With Reduced Rate of HIV Infection in Trials

Researchers noted that efficacy was greater in older women and women with better adherence

Life Expectancy Growing For Those With HIV, But Work Remains

The disparity between infected and non-infected individuals was larger in earlier data, with researchers reporting that between 1996-2006 this gap was 26.3 years. From 2007-2011 ...

CDC Data Show Gains in Viral Suppression Among People With HIV

A recent study discussed at CROI 2016 Boston shows an increase in adult HIV patients who are virally suppressed, with gains in young adults and ...

Engaging Men in HIV Clinical Trials: What Are the Challenges?

Should the focus shift to how best to reach men in trials?

Live Coverage from CROI 2016

CROI 2016 An MD's Roundup of New Data on Medications for HIV Presented at CROI 2016

An MD's Roundup of New Data on Medications for HIV Presented at CROI 2016

Some treatment failures occur most often due to the need for a high level of adherence to daily medication.

CROI 2016 Option B+ Maintained Low HIV Mother-to-Child Transmission Rates

Option B+ Maintained Low HIV Mother-to-Child Transmission Rates

In 2011, Malawi implemented Option B+, which provided lifelong antiretroviral therapy for all HIV-positive women who were pregnant or breastfeeding regardless of CD4 count.

CROI 2016 Quick ART Initiation Linked With Reduction in HIV Deaths

Quick ART Initiation Linked With Reduction in HIV Deaths

Projections for 2025 suggest that HIV-positive patients who initiate care but never begin antiretroviral therapy could account for as many as 9% to 22% of HIV-related deaths in Rwanda, Malawi, Kenya and South Africa.

CROI 2016 Two Investigational Vaccines Show Promise for Ebola Virus Disease

Two Investigational Vaccines Show Promise for Ebola Virus Disease

Two vaccine candidates are well-tolerated and immunogenic in adult volunteers.

CROI 2016 Innovations in HIV Care Needed to Achieve 90-90-90

Innovations in HIV Care Needed to Achieve 90-90-90

The most recent estimates from UNAIDS estimates suggest that 15.8 million people are being treated with antiretroviral therapy.

CROI 2016 Lifetime Risk for HIV Varies Significantly With Race, Gender, State

Lifetime Risk for HIV Varies Significantly With Race, Gender, State

Estimates suggest about half of black men who have sex with men in the United States will be diagnosed with the virus in their lifetime, according to a study presented at CROI 2016.

CROI 2016 Rise in Hepatitis C Noted Before 2015 HIV Outbreak in Indiana

Rise in Hepatitis C Noted Before 2015 HIV Outbreak in Indiana

There had been less than five HIV patients annually reported with HIV in the county, but since the start of the outbreak in late 2014, 188 people have now been diagnosed with the virus in that area.

CROI 2016 Antibodies Could Play Role in Long-Term HIV Viral Suppression

Antibodies Could Play Role in Long-Term HIV Viral Suppression

Antibodies have a distinct mechanism of action from antiretrovirals.

CROI 2016 Cotrimoxazole Not Linked With Extended Survival for HIV-exposed, Uninfected Newborns

Cotrimoxazole Not Linked With Extended Survival for HIV-exposed, Uninfected Newborns

The study was stopped early because researchers determined treatment was unlikely to show a benefit.

CROI 2016 IMPAACT: Tenofovir Not Linked With Bone Mineral Content Loss in HIV+ Newborns

IMPAACT: Tenofovir Not Linked With Bone Mineral Content Loss in HIV+ Newborns

Dr Siberry said the benefits of triple ARV treatment for both the patient and for prevention of mother to child transmission 'outweigh the concerns we see, potentially, in lower bone mineral content.'

Upcoming Meetings

Sign Up for Free e-newsletters